181 related articles for article (PubMed ID: 11093147)
1. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity.
Nakajima H; Cella M; Bouchon A; Grierson HL; Lewis J; Duckett CS; Cohen JI; Colonna M
Eur J Immunol; 2000 Nov; 30(11):3309-18. PubMed ID: 11093147
[TBL] [Abstract][Full Text] [Related]
2. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
Parolini S; Bottino C; Falco M; Augugliaro R; Giliani S; Franceschini R; Ochs HD; Wolf H; Bonnefoy JY; Biassoni R; Moretta L; Notarangelo LD; Moretta A
J Exp Med; 2000 Aug; 192(3):337-46. PubMed ID: 10934222
[TBL] [Abstract][Full Text] [Related]
3. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
Tangye SG; Phillips JH; Lanier LL; Nichols KE
J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
[TBL] [Abstract][Full Text] [Related]
4. 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism.
Nakajima H; Colonna M
Hum Immunol; 2000 Jan; 61(1):39-43. PubMed ID: 10658976
[TBL] [Abstract][Full Text] [Related]
5. Defective NK cell activation in X-linked lymphoproliferative disease.
Benoit L; Wang X; Pabst HF; Dutz J; Tan R
J Immunol; 2000 Oct; 165(7):3549-53. PubMed ID: 11034354
[TBL] [Abstract][Full Text] [Related]
6. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
Moretta A; Bottino C; Vitale M; Pende D; Cantoni C; Mingari MC; Biassoni R; Moretta L
Annu Rev Immunol; 2001; 19():197-223. PubMed ID: 11244035
[TBL] [Abstract][Full Text] [Related]
7. Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase.
Aoukaty A; Tan R
J Biol Chem; 2002 Apr; 277(15):13331-7. PubMed ID: 11815622
[TBL] [Abstract][Full Text] [Related]
8. XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells.
Meazza R; Tuberosa C; Cetica V; Falco M; Loiacono F; Parolini S; Micalizzi C; Moretta A; Mingari MC; Moretta L; Bottino C; Aricò M; Pende D
Eur J Immunol; 2014 May; 44(5):1526-34. PubMed ID: 24496997
[TBL] [Abstract][Full Text] [Related]
9. Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors.
Chen R; Relouzat F; Roncagalli R; Aoukaty A; Tan R; Latour S; Veillette A
Mol Cell Biol; 2004 Jun; 24(12):5144-56. PubMed ID: 15169881
[TBL] [Abstract][Full Text] [Related]
10. WhatSAP - 2B4 sends mixed messages in the absence of SAP.
Watzl C; Claus M
Eur J Immunol; 2014 May; 44(5):1281-4. PubMed ID: 24659462
[TBL] [Abstract][Full Text] [Related]
11. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4.
Sayós J; Nguyen KB; Wu C; Stepp SE; Howie D; Schatzle JD; Kumar V; Biron CA; Terhorst C
Int Immunol; 2000 Dec; 12(12):1749-57. PubMed ID: 11099315
[TBL] [Abstract][Full Text] [Related]
12. Role for glycogen synthase kinase-3 in NK cell cytotoxicity and X-linked lymphoproliferative disease.
Aoukaty A; Tan R
J Immunol; 2005 Apr; 174(8):4551-8. PubMed ID: 15814676
[TBL] [Abstract][Full Text] [Related]
13. The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expression.
Mooney JM; Klem J; Wülfing C; Mijares LA; Schwartzberg PL; Bennett M; Schatzle JD
J Immunol; 2004 Sep; 173(6):3953-61. PubMed ID: 15356144
[TBL] [Abstract][Full Text] [Related]
14. Dynamic redistribution of the activating 2B4/SAP complex at the cytotoxic NK cell immune synapse.
Roda-Navarro P; Mittelbrunn M; Ortega M; Howie D; Terhorst C; Sánchez-Madrid F; Fernández-Ruiz E
J Immunol; 2004 Sep; 173(6):3640-6. PubMed ID: 15356108
[TBL] [Abstract][Full Text] [Related]
15. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
[TBL] [Abstract][Full Text] [Related]
16. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells.
Dupré L; Andolfi G; Tangye SG; Clementi R; Locatelli F; Aricò M; Aiuti A; Roncarolo MG
Blood; 2005 Jun; 105(11):4383-9. PubMed ID: 15677558
[TBL] [Abstract][Full Text] [Related]
17. NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease.
Bottino C; Falco M; Parolini S; Marcenaro E; Augugliaro R; Sivori S; Landi E; Biassoni R; Notarangelo LD; Moretta L; Moretta A
J Exp Med; 2001 Aug; 194(3):235-46. PubMed ID: 11489943
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP.
Tangye SG; Lazetic S; Woollatt E; Sutherland GR; Lanier LL; Phillips JH
J Immunol; 1999 Jun; 162(12):6981-5. PubMed ID: 10358138
[TBL] [Abstract][Full Text] [Related]
19. X-linked lymphoproliferative disease: the dark side of 2b4 function.
Bottino C; Parolini S; Biassoni R; Falco M; Notarangelo L; Moretta A
Adv Exp Med Biol; 2001; 495():63-7. PubMed ID: 11774610
[No Abstract] [Full Text] [Related]
20. Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation.
Tangye SG; Nichols KE; Hare NJ; van de Weerdt BC
J Immunol; 2003 Sep; 171(5):2485-95. PubMed ID: 12928397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
